Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-03-22
2011-03-22
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S254090, C544S364000, C544S373000
Reexamination Certificate
active
07910591
ABSTRACT:
The present invention is concerned with new indol-2-one derivatives of Formula (I), which have favorable activity profile for the prophylaxis and treatment of disorders in the central nervous or in the cadiovascular system.
REFERENCES:
patent: 4452808 (1984-06-01), Gallagher, Jr. et al.
patent: 5010079 (1991-04-01), Manoury et al.
patent: 0 281 309 (1988-09-01), None
patent: 0 354 094 (1990-02-01), None
patent: 0 376 607 (1990-07-01), None
patent: WO-98/08816 (1998-03-01), None
Volk et al. J.Med. Chem. vol.51(8), p. 2522-2532 (2008).
Barkóczy József
Egyed András
Gacsályi István
Gigler Gábor
Hársing László Gábor
Bernhardt Emily
Birch & Stewart Kolasch & Birch, LLP
EGIS Gyogyszergyar NYRT.
LandOfFree
Piperazine derivatives of alkyl oxindoles does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Piperazine derivatives of alkyl oxindoles, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Piperazine derivatives of alkyl oxindoles will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2695816